Theravance and Glaxo Say Asthma Study Succeeded

Home › Theravance and Glaxo Say Asthma Study Succeeded

Theravance and GlaxoSmithKline said today that their lung disease drug Breo Ellipta worked as a treatment for asthma in a clinical trial.

01.06	Atlantic Tropical Weather Outlook
01.06	Eastern North Pacific Tropical Weather Outlook
01.06	You May Ask Yourself How Did We Get Here?
01.06	Retinol Benefits With a Natural and Safe Alternative
01.06	Tween Color Cosmetics Brand Talomi Puts a New Face on Beauty
01.06	How HCPA Racks Up Wins At State & Federal Levels
01.06	Packaging Can Be Sustainable& Beautiful
01.06	This Week in Agribusiness, June 1, 2024
More »

je.st